Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2013 1
2014 2
2015 1
2016 1
2018 1
2019 3
2020 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Sexual harassment in the healthcare workforce: what next?
O'Gara B, Hutchinson AMN, Watt J, Rees-Lee J. O'Gara B, et al. Among authors: rees lee j. Br J Surg. 2024 Jan 31;111(2):znae004. doi: 10.1093/bjs/znae004. Br J Surg. 2024. PMID: 38298066 No abstract available.
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.
Potter S, Trickey A, Rattay T, O'Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Potter S, et al. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. Br J Surg. 2020. PMID: 32073654
Improving the accuracy of intraoperative perforator location in DIEP flaps.
Tillett RL, Rees Lee JE, Jones L, Wilson SM. Tillett RL, et al. Among authors: rees lee je. J Plast Reconstr Aesthet Surg. 2014 Feb;67(2):e60-1. doi: 10.1016/j.bjps.2013.09.034. Epub 2013 Oct 10. J Plast Reconstr Aesthet Surg. 2014. PMID: 24230487 No abstract available.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
13 results